Purpose: The purpose of this study was to report the 22-year clinical outcome of a patient who underwent endokeratoplasty. Methods: To report the clinical outcomes of 37-year-old male who underwent… Click to show full abstract
Purpose: The purpose of this study was to report the 22-year clinical outcome of a patient who underwent endokeratoplasty. Methods: To report the clinical outcomes of 37-year-old male who underwent endokeratoplasty for decompensated Fuchs endothelial dystrophy in 1998. Results: After subsequent cataract surgery and iridoplasty, at 22 years post endokeratoplasty, the Snellen best spectacle-corrected visual acuity is 20/20 (−5.50 sphere −3.00 cylinder at 135 degrees), endothelial cell count is 645 cells/mm2, central corneal thickness is 644 μm, and the cornea remains clear with no evidence of graft rejection or failure. Conclusions: To the best of our knowledge, this is the longest reported outcome for selective endothelial replacement. The patient undergoing endokeratoplasty can achieve an excellent visual acuity and long-term graft survival.
               
Click one of the above tabs to view related content.